Healthy high growth potential

Results

1521

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1521 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CDR
zł237.702.9%-5.7%zł23.7bzł235.1346.030.7%0.4%Media
WAYS
SEK 38.20-3.5%-5.2%SEK 335.0mSEK 58.00203.378.5%0%Tech
AGP
€6.97-0.6%-8.7%€127.1m€8.5725.639.1%n/aCapital Goods
AXSM
US$234.20-1.2%133.2%US$12.3bUS$282.5117.057.0%n/aPharmaceuticals & Biotech
MDGL
US$538.80-1.5%83.0%US$12.7bUS$680.0011.059.6%n/aPharmaceuticals & Biotech
FWRY
ج.م18.99-1.7%45.6%ج.م64.7bج.م22.4524.327.3%n/aDiversified Financials
LPK
€13.60-18.6%66.1%€332.6m€22.753.3116.6%0%Tech
MOD
US$208.06-15.8%85.9%US$12.2bUS$340.8690.949.2%n/aCapital Goods
CORT
US$94.19-1.5%38.1%US$9.8bUS$95.75216.647.8%n/aPharmaceuticals & Biotech
NVDA
US$197.01-5.0%12.3%US$4.8tUS$302.8329.922.8%0.5%Semiconductors
RHM
€1,086.809.2%-37.4%€50.6b€1,697.8548.230.6%1.1%Capital Goods
LITE
US$651.93-22.2%495.5%US$55.4bUS$1,104.89115.556.5%n/aTech
CRDO
US$192.28-14.1%75.8%US$38.8bUS$279.2975.927.7%n/aSemiconductors
SAUD3
R$14.94-0.5%25.0%R$43.7bR$16.6277.343.7%5.4%Healthcare
301358
CN¥64.606.6%101.3%CN¥54.5bCN¥108.2621.527.0%0.6%Capital Goods
3881
HK$18.980.5%n/aHK$8.3bn/a8.1107.1%n/aCapital Goods
002384
CN¥179.78-17.3%217.0%CN¥327.7bCN¥188.00160.673.1%0%Tech
3636
HK$12.83-7.0%n/aHK$2.0bHK$31.235.140.2%3.0%Materials
NYKAA
₹327.500.3%53.2%₹937.6b₹307.92470.148.9%n/aRetail
SCHNEIDER
₹1,280.90-4.6%34.1%₹306.3b₹1,398.33144.134.0%n/aCapital Goods
SAATVIKGL
₹438.00-1.5%n/a₹55.7b₹542.5015.639.6%n/aSemiconductors
2171
HK$13.50-9.9%-43.2%HK$8.0bHK$21.1955.180.6%n/aPharmaceuticals & Biotech
APOLLO
₹383.10-5.4%123.2%₹144.0b₹382.50127.641.3%0.07%Capital Goods
002970
CN¥46.20-3.8%0.7%CN¥8.4bn/a25.836.5%2.2%Automobiles
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St